Literature DB >> 8011827

Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America.

E P Dellinger1, P A Gross, T L Barrett, P J Krause, W J Martone, J E McGowan, R L Sweet, R P Wenzel.   

Abstract

OBJECTIVE: The objectives of this quality standard are (1) to provide an implementation mechanism that will facilitate the reliable administration of prophylactic antimicrobial agents to patients undergoing operative procedures in which such a practice is judged to be beneficial and (2) to provide a guideline that will help local hospital committees formulate policies and set up mechanisms for their implementation. Although standards in the medical literature spell out recommendations for specific procedures, agents, schedules, and doses, other reports document that these standards frequently are not followed in practice. OPTIONS: We have specified the procedures in which the administration of prophylactic antimicrobial agents has been shown to be beneficial, those in which this practice is widely thought to be beneficial but in which compelling evidence is lacking, and those in which this practice is controversial. We have examined the evidence regarding the optimal timing of drug administration, the optimal dose, and the optimal duration of prophylaxis. OUTCOMES: The intended outcome is more uniform and reliable administration of prophylactic antibiotics in those circumstances where their value has been demonstrated or their use has been judged by the local practicing medical community to be desirable. The result should be a reduction in rates of postoperative wound infection in conjunction with a limitation on the quantities of antimicrobial agents used in circumstances where they are not likely to help. EVIDENCE: Many prospective, randomized, controlled trials comparing placebo with antibiotic and comparing one antibiotic with another have been conducted. In addition, some trials have compared the efficacy of different doses or methods of administration. Other papers have reported on the apparent efficacy of administration at different times and on actual practice in specific communities. Only a small group of relevant articles found through 1993 are cited herein. When authoritative reviews are available, these--rather than an exhaustive list of original references--are cited. VALUES: We assumed that reducing rates of postoperative infection was valuable but that reducing the total amount of antimicrobial agents employed was also worthwhile. The cost of and morbidity attributable to postoperative wound infections should be weighted against the cost and potential morbidity associated with excessive use of antimicrobial agents. BENEFITS, HARMS, AND COSTS: More reliable administration of antimicrobial agents according to recognized guidelines should prevent some postoperative wound infections while lowering the total quantity of these drugs used. No harms are anticipated. The costs involved are those of the efforts needed on a local basis to design and implement the mechanism that supports uniform and reliable administration of prophylactic antibiotics. RECOMMENDATIONS: All patients for whom prophylactic antimicrobial agents are recommended should receive them. The agents given should be appropriate in light of published guidelines. A short duration of prophylaxis (usually < 24 hours) is recommended. VALIDATION: More than 50 experts in infectious diseases and 10 experts in surgical infectious diseases and surgical subspecialties reviewed the standard. In addition, the methods for its implementation were reviewed by the American Society of Hospital Pharmacists. SPONSORS: The Quality Standards Subcommittee of the Clinical Affairs Committee of the Infectious Diseases Society of America (IDSA) developed the standard. The subcommittee was composed of representatives of the IDSA (P.A.G. and J.E.M.), the Society for Hospital Epidemiology of America (R.P.W.), the Surgical Infection Society (E.P.D.), the Pediatric Infectious Diseases Society (P.J.K.), the Centers for Disease Control and Prevention (W.J.M.), the Obstetrics and Gynecology Infectious Diseases Society (R.L.S.), and the Association of Practitioners of Infection Control (T.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8011827     DOI: 10.1093/clinids/18.3.422

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  51 in total

Review 1.  Antimicrobial prophylaxis.

Authors:  J Smith; A Finn
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

Review 2.  Preventing postoperative infections: current treatment recommendations.

Authors:  I C Gyssens
Journal:  Drugs       Date:  1999-02       Impact factor: 9.546

3.  Antimicrobial prophylaxis in colorectal surgery.

Authors:  A M Glenny; F Song
Journal:  Qual Health Care       Date:  1999-06

4.  [The infected implant. Part 1: bacteriology].

Authors:  U Geipel; M Herrmann
Journal:  Orthopade       Date:  2004-12       Impact factor: 1.087

5.  Mechanical bowel preparation and antimicrobial prophylaxis in elective colorectal surgery in Switzerland--a survey.

Authors:  Adrian Businger; Gabriela Grunder; Marc-Olivier Guenin; Christoph Ackermann; Ralph Peterli; Markus von Flüe
Journal:  Langenbecks Arch Surg       Date:  2010-10-24       Impact factor: 3.445

6.  A national survey of antimicrobial prophylaxis in adult cardiac surgery across Canada.

Authors:  Fran L Paradiso-Hardy; Patti Cornish; Chantal Pharand; Stephen E Fremes
Journal:  Can J Infect Dis       Date:  2002-01

7.  Application of ATC/DDD methodology to evaluate perioperative antimicrobial prophylaxis.

Authors:  Serife Akalin; Selda Sayin Kutlu; Bayram Cirak; Saadettin Yilmaz Eskiçorapcı; Dilek Bagdatli; Semih Akkaya
Journal:  Int J Clin Pharm       Date:  2011-12-30

8.  Survey of surgical antimicrobial prophylaxis in czech republic.

Authors:  Retnosari Andrajati; Jiri Vlcek; Milan Kolar; Ráchel Pípalová
Journal:  Pharm World Sci       Date:  2005-12

9.  Effectiveness of an information technology intervention to improve prophylactic antibacterial use in the postoperative period.

Authors:  Kevin Haynes; Darren R Linkin; Neil O Fishman; Warren B Bilker; Brian L Strom; Eric A Pifer; Sean Hennessy
Journal:  J Am Med Inform Assoc       Date:  2011-01-24       Impact factor: 4.497

10.  Intraoperative redosing of cefazolin and risk for surgical site infection in cardiac surgery.

Authors:  G Zanetti; R Giardina; R Platt
Journal:  Emerg Infect Dis       Date:  2001 Sep-Oct       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.